InvestorsHub Logo
Followers 79
Posts 24490
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 05/10/2019 8:21:43 AM

Friday, May 10, 2019 8:21:43 AM

Post# of 27395
GENE - .704 Pre-market now at 1.00/1.02

Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests – for Colorectal Cancer and for Breast Cancer

https://www.tradescores.com/StockReport/gene

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.